MCGH held predoctoral fellowship Ayudas al Personal Investigador en Formacin from IRBLleida/Diputacin de Lleida
Initially developed for Type 2 diabetes, they are now a leading therapy for chronic weight management
A.WoellnerC.SalzerU.et al
Weight gain can be caused by underlying medical conditions such as: Hypothyroidism PCOS Cushing syndrome Insulin resistance Diabetes Hormonal disorders An endocrinologist identifies these causes and develops a personalized treatment plan
Glucagon-like peptide-1 receptor agonists used to treat type 2 diabetes and obesity, such as Mounjaro and Ozempic, are thought to work by influencing the brains reward pathways in order to cut cravings
When taken therapeutically, specific peptides can trigger your bodys own systems to repair tissue, regulate inflammation, support hormone production, or accelerate fat metabolism